Current update on medullary thyroid carcinoma

作者: Dhakshinamoorthy Ganeshan , Erik Paulson , Cihan Duran , Maria E. Cabanillas , Naifa L. Busaidy

DOI: 10.2214/AJR.12.10370

关键词:

摘要: OBJECTIVE. This article will review the multimodality imaging spectrum of medullary thyroid carcinoma (MTC) with an emphasis on anatomic and functional imaging. Recent advances in molecular cytogenetics this tumor impact diagnosis, prognosis, development novel targeted therapy be discussed. CONCLUSION. MTC is a neuroendocrine unique clinicopathologic radiologic features compared other malignancies. Imaging plays important role optimal management malignancy.

参考文章(101)
Shinya Uchino, Shiro Noguchi, Mitsuo Adachi, Mari Sato, Hiroyuki Yamashita, Shin Watanabe, Tsukasa Murakami, Masakatsu Toda, Nobuo Murakami, Hiroto Yamashita, Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas. Japanese Journal of Cancer Research. ,vol. 89, pp. 411- 418 ,(1998) , 10.1111/J.1349-7006.1998.TB00579.X
Salvador J. Diaz-Cano, Manuel de Miguel, Alfredo Blanes, Robert Tashjian, Hubert J. Wolfe, Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia The Journal of Clinical Endocrinology and Metabolism. ,vol. 86, pp. 3948- 3957 ,(2001) , 10.1210/JCEM.86.8.7739
Mauro Papotti, Daniela Sambataro, Carla Pecchioni, Gianni Bussolati, The pathology of medullary carcinoma of the thyroid: Review of the literature and personal experience on 62 cases Endocrine Pathology. ,vol. 7, pp. 1- 20 ,(1996) , 10.1007/BF02739911
Leslie S Wu, Sanziana A Roman, Julie A Sosa, Medullary thyroid cancer: an update of new guidelines and recent developments Current Opinion in Oncology. ,vol. 23, pp. 22- 27 ,(2011) , 10.1097/CCO.0B013E328340B527
Jerzy Kosowicz, Renata Mikołajczak, Rafał Czepczyński, Katarzyna Ziemnicka, Maria Gryczyńska, Jerzy Sowiński, Two Peptide Receptor Ligands 99mTc-EDDA/HYNIC-Tyr3-Octreotide and 99mTc-EDDA/HYNIC-DGlu-Octagastrin for Scintigraphy of Medullary Thyroid Carcinoma Cancer Biotherapy and Radiopharmaceuticals. ,vol. 22, pp. 613- 628 ,(2007) , 10.1089/CBR.2006.368
Charis Eng, David Clayton, Isabelle Schuffenecker, Gilbert Lenoir, Gilbert Cote, Robert F Gagel, Hans Kristian Ploos Van Amstel, Cornelis JM Lips, Isamu Nishisho, Shin-Ichiro Takai, Debbie J Marsh, Bruce G Robinson, Karin Frank-Raue, Friedhelm Raue, Feiyu Xue, Walter W Noll, Cristina Romei, Furio Pacini, Monika Fink, Bruno Niederle, Jan Zedenius, Magnus Nordenskjöld, Paul Komminoth, Geoffrey N Hendy, Hossein Gharib, Stephen N Thibodeau, André Lacroix, Andrea Frilling, Bruce AJ Ponder, Lois M Mulligan, The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis JAMA: The Journal of the American Medical Association. ,vol. 276, pp. 1575- 1579 ,(1996) , 10.1001/JAMA.276.19.1575
Koenraad J. Mortelé, Pablo R. Ros, Cystic Focal Liver Lesions in the Adult: Differential CT and MR Imaging Features RadioGraphics. ,vol. 21, pp. 895- 910 ,(2001) , 10.1148/RADIOGRAPHICS.21.4.G01JL16895
Sophia Koukouraki, Ludwig G. Strauss, Vassilios Georgoulias, Michael Eisenhut, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss, Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 33, pp. 1115- 1122 ,(2006) , 10.1007/S00259-006-0110-X